Elevance Health, Inc.

ELV Healthcare Healthcare Plans

Elevance Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $199.1 billion, up 12.5% from fiscal 2024. In the quarter to June 2026, revenue grew 1.40%, EPS fell 13.1%, free cash flow fell 9.01% and total debt rose 4.08%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten; insiders bought in the last twelve months.

428.26 0.17 −0.04%
Market cap
$92.9B
P/E
19.0×
Fwd P/E
20.3×
Dividend yield
1.60%
F-score
6/9
Altman Z
3.09
Beneish M
−2.26
Dividend safety
96/100
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
17.19 12.45 13.96 13.21

+8 more quarters

P/S ratio
0.42 0.32 0.39 0.37
P/FCF ratio
13.34 9.98 24.74 19.15
P/Operating CF
43.87 14.85 934.80 63.57
P/B ratio
1.86 1.46 1.78 1.64
EV/Sales
0.39 0.29 0.37 0.35
EV/EBITDA
8.79 6.38 7.69 6.78
EV/FCF
12.32 9.05 23.41 18.01
Current Ratio
1.52 1.48 1.54 1.56
Net Debt/EBITDA
(2.43) (1.98) (4.27) (2.00)
Debt/Equity
0.69 0.71 0.72 0.72
Earnings Yield
5.82% 8.03% 7.17% 7.57%
Free Cash Flow Yield
7.49% 10.02% 4.04% 5.22%
Free Cash Flow per Share
7.49 18.64 (0.93) 3.47
Book value per Share
207.47 200.37 196.54 197.41
Free Cash Flow
1,626.00 4,097.00 (209.00) 775.00
EV/EBIT
10.61 7.65 9.16 8.01
Other line items

Show all line items

Columns are period end dates